Gastroenterology

Biologics for IBD – Monotherapy Versus Combination Approaches With Drs. Edward Loftus and Marla Dubinsky

Biologics for IBD – Monotherapy Versus Combination Approaches With Drs. Edward Loftus and Marla Dubinsky

In this podcast, experts review appropriate applications of monotherapy an…

Expiration Date: 8/30/2022

Max Credits: 0.25

View Activity

New Insights on Treat to Target in Moderate to Severe IBD With Drs. Edward Loftus and Miguel Regueiro

New Insights on Treat to Target in Moderate to Severe IBD With Drs. Edward Loftus and Miguel Regueiro

In this podcast, expert clinicians will discuss the shift from symptom-bas…

Expiration Date: 8/30/2022

Max Credits: 0.25

View Activity

Extraintestinal Manifestations of IBD With Drs. Edward Loftus and Miguel Regueiro

Extraintestinal Manifestations of IBD With Drs. Edward Loftus and Miguel Regueiro

In this podcast, expert clinicians review the variety of extraintestinal m…

Expiration Date: 8/30/2022

Max Credits: 0.25

View Activity

Immunogenicity of Current IBD Biologics With Drs. Edward Loftus and Marla Dubinsky

Immunogenicity of Current IBD Biologics With Drs. Edward Loftus and Marla Dubinsky

In this podcast, expert clinicians compare the immunogenicity of available…

Expiration Date: 8/30/2022

Max Credits: 0.25

View Activity

Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti

Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti

In this podcast, expert clinicians will discuss new evidence on investigat…

Expiration Date: 3/23/2022

Max Credits: 0.25

View Activity

Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn

Efficacy and Safety of Anti-integrin and Sphingosine-1-Phosphate (S1P)-1 Receptor Modulators with Drs. Bruce E. Sands and William J. Sandborn

In this podcast, expert clinicians will discuss new evidence on investigat…

Expiration Date: 3/23/2022

Max Credits: 0.25

View Activity

Mechanisms of Action of New Classes of Agents for Moderate to Severe Crohn’s Disease with Drs. William J. Sandborn and Bruce E. Sands

Mechanisms of Action of New Classes of Agents for Moderate to Severe Crohn’s Disease with Drs. William J. Sandborn and Bruce E. Sands

In this podcast, expert clinicians will discuss emerging therapies with un…

Expiration Date: 3/23/2022

Max Credits: 0.25

View Activity

Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 Inhibitors

Investigational Agents in Ulcerative Colitis: IL-12 and IL-23 Inhibitors

Inflammatory bowel disease, which includes ulcerative colitis (UC) and Cro…

Expiration Date: 4/29/2020

Max Credits: 0

View Activity

Investigational Agents in Ulcerative Colitis: JAK Inhibitors and S1P Receptor Modulators

Investigational Agents in Ulcerative Colitis: JAK Inhibitors and S1P Receptor Modulators

Inflammatory bowel disease, which includes ulcerative colitis (UC) and Cro…

Expiration Date: 4/29/2020

Max Credits: 0

View Activity

Investigational Agents in Ulcerative Colitis: Anti-Integrins

Investigational Agents in Ulcerative Colitis: Anti-Integrins

Inflammatory bowel disease, which includes ulcerative colitis (UC) and Cro…

Expiration Date: 4/29/2020

Max Credits: 0

View Activity